Equities are a key component of every investor’s portfolio, making it important to learn the fundamentals and technicals required to invest successfully and with confidence. Discover how top professional investors separate fact from fiction to maximize their profit opportunities. From explosive IPOs to solid value plays, our experts can help you formulate the right action plan for your portfolio no matter where the markets are headed.

Articles on Stocks

The main reason why the price of any asset changes/fluctuates in the financial market is the changing rate is supply and demand, explains Konstantin Rabin of Top Forex Brokers.
It’s no secret all casino, resort, and travel-related stocks have suffered in the wake of the year-long Covid-19 pandemic, notes Bernie Schaeffer, founder and CEO at Schaeffer Investment Research, an industry leading provider of market timing and options investing and trading advice.
As a global manufacturing company, Deere (DE) is affected by trends in trade policies, exchange rates and commodity prices. However, Deere management understands, and does a good job of managing the factors it can control, such as pricing and costs, notes John Eade, President of Argus Research.
NextEra Energy (NEE) is a leading clean energy company. It was previously known as Florida Power and Light (FPL), which is now a division of NEE, notes Genia Turanova, income expert, CFA and a contributing editor to The Dollar Stock Club.
Companies have been transitioning their manufacturing jobs to machines for years, but we’re about to see it on a much broader scale, forecasts Sean Brodrick, a leading growth stock expert and editor of Wealth Megatrends.
Shares of Sprouts Farmers Market (SFM) rose after the company reported favorable results for the final quarter of 2020, observes Taesik Yoon, growth stock expert and editor of Forbes Investor.
Gavin Graham, contributing editor to The Income Investor, has a long career in money management and international securities, holding senior positions in financial organizations in London, Hong Kong, and Toronto; here, he looks at two London-based plays in the food and beverage sectors.
Merck (MRK), headquartered in New Jersey, is one of the largest pharmaceutical companies in the world. Its stock has a market cap near $190 billion, explains Richard Suttmeier, growth stock expert and editor of 2-Second Trader.
CEO Jeff Sprecher and his Board of Directors at Intercontinental Exchange (ICE) recently dished us a 10% dividend increase; the shares now pay $0.33 each quarter versus $0.30 previously, observes income specialist Brett Owens, editor of Hidden Yields.
Stocks opened strong Monday and continued to rally all the way into the close as President Biden's $1.9 trillion stimulus program advanced to the Senate, notes Jon Markman of Pivotal Point.

Experts on Stocks

Virtual Expos

Virtual Learning

Join Thomas Lee, managing partner of Fundstrat Global Advisors, to learn about the probable path of markets in 2021 and what themes and stocks are likely to outperform.
No, Kelley Wright is not talking politics. Since the introduction of QE into the markets in '08-'09, the markets, and therefore market participants, have enjoyed an environment where they have in large part been protected by the Fed monetarily and from the Congress fiscally. Inflation, the real kind in the real world, not the phony bologna stuff regurgitated by an intentionally obtuse media, is starting to show signs of emergence. The bond market, which has been AWOL since '08-'09, is starting to exhibit a heartbeat. In an inflationary, rising interest rate environment, active management, the ability to pick stocks that are high-quality and offer good value, will outperform passive indexing. In this workshop Kelley Wright will demonstrate the IQ Trends method of identifying high-quality stocks and when they offer good value.

John McCamant, editor of The Medical Technology Stock Letter, is known for helping investors pick biotech winners. Join this session to discover a unique investment opportunity in a repurposed Phase II pill, poised to treat Covid-19 by reducing viral load.
Zhittya Genesis Medicine, Inc., is developing novel pharmaceuticals that have the potential to treat and reverse diseases that account for more than 50% of all adult deaths, worldwide. In FDA-authorized clinical trials these drugs have shown remarkable success in reversing severe coronary artery disease and healing chronic diabetic foot ulcers. New clinical trials are planned in the coming year to treat patients with Parkinson's disease, ALS (Lou Gehrig's disease), multiple sclerosis, chronic stroke, and Alzheimer's disease. A very attractive Pre-IPO investment is now being offered to suitable investors to help fund the upcoming IPO, which has a firm commitment from a highly regarded securities firm and will take place in 5-6 months.
A common approach among investors is to buy the dips, when accumulating stock. But does this actually work? Jonathan Hoenig, a portfolio manager and Fox News contributor, will highlight the alternative approach that's helped him best S&P 500 for over 20 years.
China was the real winner from the US presidential election. The Biden Administration is staffed by "globalists" that will resume outsourcing both manufacturing and services. Our Chinese ADRs have been hotter than not. Louis Navellier will explain which Chinese ADRs are his favorites and explain why China is expected to dominate key industries.
A sharp reduction in interest rates in 2020 pushed up valuations of long-duration assets, including bonds and growth stocks, to very high levels. One of the biggest risks and opportunities for multiple asset classes for the next few years is navigating the inflation cycle and the prospect of a steepening yield curve as this duration trade potentially unwinds.

This presentation will discuss the catalysts behind the 2020 rally, the growing disconnect between the market and the economy, and why investors should be increasingly concerned about stocks in the Covid-impacted market. For the foreseeable future, however, equities remain the best way to generate income and grow wealthyou know how to pick the right investments.

Some of the most promising stocks today belong to a category Genia Turanova calls LIAs, or leveraged investment assets. The best of the best LIAs are a triple-treat: they can grow revenue, profits, and dividends. In this presentation, she discusses a few of her favorites.

To benefit from the long-term power of LIAs, investors must stay in the market. And the safest way is to buy market insurance through put options. Ms. Turanova explains why these vehicles are her favorite hedge and how to use them with LIAs to maximum advantage.

As conventional venture capital funds pile into the hottest start-up prospects, waiting for the IPO window isn't always a great option. We've done extremely well with "back door" offerings that bypass Wall Street, and now the rules are relaxing as regulators acknowledge that this system for matching investors with opportunities is the future. Hilary Kramer, author of the best-selling GameChanger Investing and editor of IPO Edge, has earned elite subscribers a lot of triple-digit wins in her career. Now she's eager to take those rarefied returns up another level, taking you into realms once reserved for the ultimate market insiders.



While the mechanisms and machinations of the markets have changed a lot since Benjamin Graham first devised a practical method for analyzing stocks, or even since Peter Lynch racked up big wins picking equities for Fidelity's Magellan Fund, one thing remains true: companies that deliver constant profits for shareholders will see their share prices increase.

Lofty current valuations show that the easy money has already been made, and those looking to profit should be more selective going forward. So which sectors will lead the market over the months ahead? What’s the best way to limit risk in the current environment? You will find the answers to these questions and more from the top industry professionals on these pages, unlike watching the stock market news on TV. Going beyond the stock market news today, many investors are searching for investments that they can depend on. Of course, there's no such thing as a sure bet, but the top experts featured here will share the picks they think are the next best things and the sectors that are bound to thrive in the days and months ahead.

The current market environment is particularly well-suited for stock pickers and stock-trading experts—especially the experts featured here whose careers are devoted to uncovering the best opportunities available in even the most rapidly changing environment. Get easy access to the nation’s leading stock experts who regularly share their takes on where market trends are headed, where to find bargains, and how to stay ahead of the curve.

Watch videos and read articles by these experts and discover their outlooks on what’s ahead for stocks, but more importantly, identify the most compelling sectors and industry groups, as well as the specific buying opportunities for optimal growth or income. These pages are chock-full of valuable insights from our experts' varying perspectives and expertise.